Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives

Introduction of antiplatelet agents has contributed substantially to improve the outcome of patients with acute coronary syndromes. Meta-analysis of the studies on abciximab administration during primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziewierz, Artur, Rakowski, Tomasz, Dudek, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111647/
https://www.ncbi.nlm.nih.gov/pubmed/25071373
http://dx.doi.org/10.2147/TCRM.S50002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111647/
https://www.ncbi.nlm.nih.gov/pubmed/25071373
http://dx.doi.org/10.2147/TCRM.S50002

Ejemplares similares